Comparison across all cancer cell lines indicated that the HAT inhibitor A485 had a greater effect on growth suppression than the BRD inhibitor CCS1477 (Supplementary Fig. 1b), and that the individual effects of CCS1477 and A485 across all cell lines were not well correlated (R2 = 0.13). The gene discussed is TMPRSS11D; the disease is cancer.